LILRB4 expression in chronic myelomonocytic leukemia and myelodysplastic syndrome based on response to hypomethylating agents.


Journal

Leukemia & lymphoma
ISSN: 1029-2403
Titre abrégé: Leuk Lymphoma
Pays: United States
ID NLM: 9007422

Informations de publication

Date de publication:
06 2020
Historique:
pubmed: 11 2 2020
medline: 24 4 2021
entrez: 11 2 2020
Statut: ppublish

Résumé

LILRB4 is expressed in AML M4/M5 cells and negatively regulates immune cell activation

Identifiants

pubmed: 32036728
doi: 10.1080/10428194.2020.1723014
pmc: PMC7836710
mid: NIHMS1661520
doi:

Substances chimiques

LILRB4 protein, human 0
Membrane Glycoproteins 0
Receptors, Immunologic 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1493-1499

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016672
Pays : United States
Organisme : NCI NIH HHS
ID : T32 CA009666
Pays : United States

Références

Mol Ther. 2018 Oct 3;26(10):2487-2495
pubmed: 30131301
Adv Immunol. 2015;127:33-144
pubmed: 26073983
Nature. 2018 Oct;562(7728):605-609
pubmed: 30333625
Blood. 2006 Jul 15;108(2):419-25
pubmed: 16609072
Genome Biol. 2013 Apr 25;14(4):R36
pubmed: 23618408
Curr Oncol Rep. 2019 Mar 23;21(4):37
pubmed: 30904967
Cytometry B Clin Cytom. 2013 Jan-Feb;84(1):21-9
pubmed: 23027709
Genome Biol. 2014;15(12):550
pubmed: 25516281
J Immunol. 2006 Mar 1;176(5):2790-8
pubmed: 16493035
Cell Cycle. 2016;15(1):25-40
pubmed: 26636629
Trends Immunol. 2017 Jul;38(7):513-525
pubmed: 28511816
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Clin Cancer Res. 2018 Aug 1;24(15):3519-3527
pubmed: 29716921
Blood Rev. 2019 Mar;34:67-83
pubmed: 30553527
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Oncoimmunology. 2015 Mar 19;4(7):e1014242
pubmed: 26140237
J Immunol. 2007 Jun 1;178(11):7432-41
pubmed: 17513794
Blood. 1997 Mar 15;89(6):2079-88
pubmed: 9058730
J Exp Med. 1997 May 19;185(10):1743-51
pubmed: 9151699

Auteurs

Kelly S Chien (KS)

Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Caleb A Class (CA)

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Guillermo Montalban-Bravo (G)

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Yue Wei (Y)

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Koji Sasaki (K)

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Kiran Naqvi (K)

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Irene Ganan-Gomez (I)

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Hui Yang (H)

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Kelly A Soltysiak (KA)

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Rashmi Kanagal-Shamanna (R)

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Kim-Anh Do (KA)

Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Hagop M Kantarjian (HM)

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Guillermo Garcia-Manero (G)

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH